Jasdeep Singh

Jasdeep Singh serves as a Board Observer for Ethris and Achira Labs Pvt. Ltd., and holds the position of Chief Strategy Officer and Chief of Staff at Cipla since September 2019, focusing on medium and long-term strategy as well as leading mergers and acquisitions for global businesses. Additional roles include Board Member at Wellthy Therapeutics and former Board Observer at GoApptiv Private Limited. Prior experience includes working as a Senior Principal at IQVIA, and as a Senior Consultant at Monitor Group, where advisory work spanned across various sectors. Jasdeep began tenure at Ranbaxy as Executive Assistant to the CEO, Atul Sobti. Educational credentials include a PhD in Chemical Engineering from the University of Cambridge, a CTES in Technology Commercialization from London Business School, and an exchange program at MIT. Early education includes a dual degree in Biochemical Engineering and Biotechnology from the Indian Institute of Technology, Delhi.